Streetbeat News

Price Targets

CYTK

JMP Securities analyst Jason Butler reiterated a Market Outperform rating on Cytokinetics (NASDAQ:CYTK) and maintained a $71 price target.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:50 pm

LAZ

JMP Securities analyst Devin Ryan reiterated a Market Outperform rating on Lazard (NYSE:LAZ) and maintained a $53 price target.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:50 pm

CRM

JMP Securities analyst Patrick Walravens has reiterated a Market Perform rating on Salesforce (NYSE:CRM) and maintained a $250 price target.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:48 pm

PUBM

RBC Capital analyst Matthew Schultheis maintains an Outperform rating on PubMatic (NASDAQ:PUBM) and raises the price target from $18 to $20.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:47 pm

BPOP

RBC Capital analyst Gerard Cassidy reiterates an Outperform rating on Popular (NASDAQ:BPOP) and maintains a $64 price target.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:46 pm

NEP

RBC Capital analyst Shelby Tucker maintains an Outperform rating on NextEra Energy Partners (NYSE:NEP) but lowers the price target from $74 to $73.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:46 pm

TRIP

DA Davidson analyst Tom White maintains a Buy rating on TripAdvisor (NASDAQ:TRIP) but lowers the price target from $28 to $25.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:44 pm

ICPT

RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating on Intercept Pharma (NASDAQ:ICPT) and maintained a $17 price target.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:43 pm

BKNG

DA Davidson analyst Tom White maintains a Neutral rating on Booking Holdings (NASDAQ:BKNG) and raises the price target from $2600 to $2700.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:42 pm